Is Anavex Life Stock a Good Investment?
Anavex Life Investment Advice | AVXL |
- Examine Anavex Life's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Anavex Life's leadership team and their track record. Good management can help Anavex Life navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Anavex Life's business and its evolving consumer preferences.
- Compare Anavex Life's performance and market position to its competitors. Analyze how Anavex Life is positioned in terms of product offerings, innovation, and market share.
- Check if Anavex Life pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Anavex Life's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Anavex Life Sciences stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Anavex Life Sciences is a good investment.
Sell | Buy |
Hold
Market Performance | Good | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Anavex Life Stock
Researching Anavex Life's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 32.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.51. Anavex Life Sciences had not issued any dividends in recent years. The entity had 1:4 split on the 7th of October 2015.
To determine if Anavex Life is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Anavex Life's research are outlined below:
| Anavex Life Sciences appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (47.51 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Anavex Life Sciences currently holds about 149.16 M in cash with (27.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.91. | |
| Anavex Life Sciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Security Paper Market Size to Reach Worth of USD 23.68 Billion by 2031 SkyQuest Technology |
Anavex Life uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Anavex Life Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Anavex Life's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 6th of February 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 25th of November 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of September 2023 Last Financial Announcement | View |
Earnings surprises can significantly impact Anavex Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Anavex Life's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2018-05-10 | 2018-03-31 | -0.1 | -0.11 | -0.01 | 10 | ||
2024-08-06 | 2024-06-30 | -0.16 | -0.14 | 0.02 | 12 | ||
2024-05-09 | 2024-03-31 | -0.11 | -0.13 | -0.02 | 18 | ||
2023-05-09 | 2023-03-31 | -0.19 | -0.17 | 0.02 | 10 | ||
2023-02-07 | 2022-12-31 | -0.19 | -0.17 | 0.02 | 10 | ||
2022-11-28 | 2022-09-30 | -0.16 | -0.18 | -0.02 | 12 | ||
2021-05-13 | 2021-03-31 | -0.14 | -0.12 | 0.02 | 14 | ||
2020-02-06 | 2019-12-31 | -0.14 | -0.12 | 0.02 | 14 |
Know Anavex Life's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Anavex Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Anavex Life Sciences backward and forwards among themselves. Anavex Life's institutional investor refers to the entity that pools money to purchase Anavex Life's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Two Sigma Advisers, Llc | 2024-09-30 | 493.5 K | Oz Management Llc | 2024-09-30 | 370.4 K | Millennium Management Llc | 2024-09-30 | 341 K | Renaissance Technologies Corp | 2024-09-30 | 243.8 K | Susquehanna International Group, Llp | 2024-09-30 | 238.4 K | Bank Of New York Mellon Corp | 2024-09-30 | 225 K | Jane Street Group Llc | 2024-06-30 | 181.9 K | Nuveen Asset Management, Llc | 2024-09-30 | 179 K | Barclays Plc | 2024-09-30 | 155.2 K | Blackrock Inc | 2024-06-30 | 6.4 M | Vanguard Group Inc | 2024-09-30 | 4.7 M |
Anavex Life's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 802.17 M.Market Cap |
|
Anavex Life's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.28) | (0.29) | |
| Return On Capital Employed | (0.45) | (0.43) | |
| Return On Assets | (0.28) | (0.29) | |
| Return On Equity | (0.39) | (0.40) |
Determining Anavex Life's profitability involves analyzing its financial statements and using various financial metrics to determine if Anavex Life is a good buy. For example, gross profit margin measures Anavex Life's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Anavex Life's profitability and make more informed investment decisions.
Evaluate Anavex Life's management efficiency
Anavex Life Sciences has return on total asset (ROA) of (0.2043) % which means that it has lost $0.2043 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3003) %, meaning that it created substantial loss on money invested by shareholders. Anavex Life's management efficiency ratios could be used to measure how well Anavex Life manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.29. Return On Capital Employed is expected to rise to -0.43 this year. At this time, Anavex Life's Total Assets are quite stable compared to the past year. Total Current Assets is expected to rise to about 186.4 M this year, although the value of Other Assets will most likely fall to about 3.7 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.60 | 1.68 | |
| Tangible Book Value Per Share | 1.60 | 1.68 | |
| Enterprise Value Over EBITDA | (6.00) | (6.30) | |
| Price Book Value Ratio | 3.32 | 3.48 | |
| Enterprise Value Multiple | (6.00) | (6.30) | |
| Price Fair Value | 3.32 | 3.48 | |
| Enterprise Value | 334.4 M | 351.1 M |
The management strategies employed by Anavex Life's are designed to enhance shareholder value and ensure long-term growth. We assess the effectiveness of these strategies in our stock analysis.
Beta 0.604 |
Basic technical analysis of Anavex Stock
As of the 2nd of December, Anavex Life shows the mean deviation of 3.43, and Risk Adjusted Performance of 0.1368. Anavex Life Sciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Anavex Life Sciences coefficient of variation, as well as the relationship between the treynor ratio and semi variance to decide if Anavex Life Sciences is priced correctly, providing market reflects its regular price of 9.32 per share. Given that Anavex Life has jensen alpha of 0.5497, we suggest you to validate Anavex Life Sciences's prevailing market performance to make sure the company can sustain itself at a future point.Anavex Life's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Anavex Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on Anavex Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Anavex Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Athanasios Skarpelos over six months ago Acquisition by Athanasios Skarpelos of 50000 shares of Anavex Life at 5.36 subject to Rule 16b-3 | ||
Christopher Missling over a year ago Exercise or conversion by Christopher Missling of 268000 shares of Anavex Life subject to Rule 16b-3 |
Anavex Life's Outstanding Corporate Bonds
Anavex Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Anavex Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Anavex bonds can be classified according to their maturity, which is the date when Anavex Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Anavex Life's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Anavex Life's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1368 | |||
| Market Risk Adjusted Performance | 0.3863 | |||
| Mean Deviation | 3.43 | |||
| Semi Deviation | 3.16 | |||
| Downside Deviation | 3.81 | |||
| Coefficient Of Variation | 595.88 | |||
| Standard Deviation | 5.02 | |||
| Variance | 25.15 | |||
| Information Ratio | 0.1404 | |||
| Jensen Alpha | 0.5497 | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | 0.1846 | |||
| Treynor Ratio | 0.3763 | |||
| Maximum Drawdown | 30.62 | |||
| Value At Risk | (7.22) | |||
| Potential Upside | 10.31 | |||
| Downside Variance | 14.55 | |||
| Semi Variance | 10.0 | |||
| Expected Short fall | (4.44) | |||
| Skewness | 1.29 | |||
| Kurtosis | 4.15 |
| Risk Adjusted Performance | 0.1368 | |||
| Market Risk Adjusted Performance | 0.3863 | |||
| Mean Deviation | 3.43 | |||
| Semi Deviation | 3.16 | |||
| Downside Deviation | 3.81 | |||
| Coefficient Of Variation | 595.88 | |||
| Standard Deviation | 5.02 | |||
| Variance | 25.15 | |||
| Information Ratio | 0.1404 | |||
| Jensen Alpha | 0.5497 | |||
| Total Risk Alpha | (0.01) | |||
| Sortino Ratio | 0.1846 | |||
| Treynor Ratio | 0.3763 | |||
| Maximum Drawdown | 30.62 | |||
| Value At Risk | (7.22) | |||
| Potential Upside | 10.31 | |||
| Downside Variance | 14.55 | |||
| Semi Variance | 10.0 | |||
| Expected Short fall | (4.44) | |||
| Skewness | 1.29 | |||
| Kurtosis | 4.15 |
Consider Anavex Life's intraday indicators
Anavex Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Anavex Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 101814.0 | |||
| Daily Balance Of Power | (0.20) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 9.66 | |||
| Day Typical Price | 9.54 | |||
| Price Action Indicator | (0.41) | |||
| Period Momentum Indicator | (0.14) |
Anavex Life Corporate Filings
10Q | 6th of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 30th of July 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 29th of July 2024 Other Reports | ViewVerify | |
F4 | 17th of June 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Anavex Stock media impact
Far too much social signal, news, headlines, and media speculation about Anavex Life that are available to investors today. That information is available publicly through Anavex media outlets and privately through word of mouth or via Anavex internal channels. However, regardless of the origin, that massive amount of Anavex data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Anavex Life news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Anavex Life relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Anavex Life's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Anavex Life alpha.
Anavex Life Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Anavex Life can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Anavex Life Corporate Management
| CPA CPA | Principal Treasurer | Profile | |
| David RPh | Senior Affairs | Profile | |
| Juan MD | Senior Development | Profile | |
| Dr RPh | VP Affairs | Profile | |
| Kun Jin | Head Biostatistics | Profile | |
| Terrie Kellmeyer | Senior Development | Profile |
Already Invested in Anavex Life Sciences?
The danger of trading Anavex Life Sciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Anavex Life is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Anavex Life. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Anavex Life Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Anavex Life Sciences is a strong investment it is important to analyze Anavex Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Anavex Life's future performance. For an informed investment choice regarding Anavex Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.51) | Return On Assets (0.20) | Return On Equity (0.30) |
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Anavex Life's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.